Prevalence of oral lesions by Candida sp: Their varieties and serotypes in a population of patients with AIDS under a highly active antiretroviral therapy;Prevalencia de lesiones orales por Candida en una población con sida sometida a terapia antirretroviral altamente activa

Revista Iberoamericana de Micologia

Volumn 15, Issue 3, 1998, Pages 141-145

  Salobreña, Alejandro Ceballos ^a,d   Gaitán Cepeda, Luis A ^b   Ruesga, María Teresa ^c   García, Laura Ceballos ^a   Quindós, Guillermo ^c  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d NONE   (Spain)

Author keywords

AIDS; Antirretroviral agents; Candida dubliniensis; Candidosis; Protease inhibitors

Indexed keywords

EID: 0001437685     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Mallolas J, Arrizabalaga J, Loncá M, et al. Cytomegalovirus disease in HIV-1-infected patients treated with protease inhibitors. AIDS 1997;11:1784-1786
2. Gatell JM, Mensa J, Zamora L. Indioaciones del saquinavir. Resúmen de los principales estudios y ensayos clinicos. En Saquinavir: El primer inhibidor de la proteasa del VIH. Barcelona, Doyma, 1997: 133-145.
3. Mars ME, Loi S, Suzan V, Gallais H Protease inhibitors lead to a change of infection disease unit activity. Fourth conference on retroviruses and opportunistic Infections. Washington DC, 1977 (Abstract 203).
4. Flaitz CM, Jin YT, Hicks MJ, Nichols CM, Wang YW, Su U, Kaposi's sarcoma-associated herpesvirus-like DNA sequences (KSHV/HHV-8) in oral AIDS-Kaposi's sarcoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83:259-264.
5. Erridge PL, Hodgson T, Lewis D, McLaren A, Zakrzewska JM. Aetiological factors for oral manifestations of HIV. Oral Dis 1996; 2:193-197.
6. EEC Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus Classification and diagnostic criteria for oral lesions in HIV infection J Oral Pathol Med 1993; 22:289-291.
7. Holmstrup P, Axell T. Classification and clinical manifestation of oral yeasts infections. Acta Odontol Scand 1990; 48:57-61.
8. Sullivan DJ, Henman MC, Woran GP, et al. Molecular genetic approaches to identification, epidemiology and taxonomy of nonalbicans Candida species. J Med Microbiol 1996; 44:399-408.
9. Bikandi J, San Millán R, Moragues MD, et al. Rapid identification of Candida dubliniensis by indirect immunofluorescence. J Clin Microbiol 1998; 36: 2428-2433
10. Barturen B, Bikandi J, San Millán R, et al. Variability in expression of antigens responsible for serotype specificity in Candida albicans. Microbiology 1995; 141:1535-1543.
11. Quindós G, San Millán R, Burgos A, et al. Evaluación de la sensibilidad a los antifúngicos de aislamientos clínicos de los serotipos A y B de Candida albicans mediante el metodo ATB Fungus®. Enferm Infecc Microbiol Clin 1995; 13: 209-212.
12. a ed). Barcelona, Masson, 1998.
13. Roca B, Simón E. Inhibidores de la proteasa del virus de la inmunodeficiencia humana. Mod Clin (Barc.) 1998; 110: 375-377.
14. Fisher-Hoch SP, Hutwagner L. Opportunistic candidiasis: an epidemic of the 1980s. Clin Infect Dis 1995; 21: 897-904
15. Ceballos-Salobreña A, Aguirre-Urizar JM, Bagán Sebastián JV. Oral manifestations associated with human immunodeficiency virus infection in a Spanish population. J Oral Pathol Med 1996; 25:523-526
16. Ceballos Salobreña A, Cebalios García L. Influencia de los inhibidores de la proteasa del VIH, asociados a otros antiretrovirales, en la aparición de las lesiones orales asociadas al Sida. Evolución de las mismas. Arch Odontoestomatol 1998; en prensa.
17. Ceballos Salobreña A, Aguirre JM, Echebarria MA, Ceballos L. Prevalencia y distribución de las candidosis orales en pacientes con SIDA establecido. Med Oral 1996; 1:6-10.
18. Ceballos Salobreña A, Antúnez Gálvez JM, Bagán Sebastián JV, Aguirre Urizar JM, Ceballos García L. Lesiones orales asociadas a la infección por el virus de la inmunodeficiencia humana en una población de 510 enfermos. Med Oral 1998; 3:199-206.
19. Ceballos Salobreña A, Bagán Sebastián JV, Quindós Andrés G, Ceballos García L. Influencia de las diferentes prácticas de riesgo en la aparición de candidosis oral en enfermos de Sida. Med Oral 1998; en prensa.
20. Ceballos Salobreña A, Olea Barrionuevo D, Aguirre Urizar JM, et al. Candidiasis bucal en pacientes infectados por VIH. Aspectos clinicos y microbiológicos Actual Obstet Ginecol 1998; X: 85-90.
21. Kolokotronis A, Kioses V, Antoniades D, Mandraveli K, Doutsos I, Papanayotou P. Immunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia. Oral Surg Oral Med Oral Pathol 1994; 78:41-46
22. Rinaldi MG Biology and pathogenecity of Candida species. En Bodey GP (Ed.) Candidosis: pathogenesis, diagnosis and treatment New York, Raven Press, 1993: 1-20.
23. Odds FC. Candida and candidosis. London, Baillière Tindall, 1988.
24. Barturen B, Quindós G, San Millán R, et al. Distribución de los serotipos de Candida albicans en aislamientos clínicos de personas inmunocompetentes e inmunosuprimidas. Rev Iberoam Micol 1996, 13: 10-13.
25. Brawner DL, Cutler JE, Yuen KY. Serotype prevalence of Candida albicans from blood culture isolates. J Clin Microbiol 1992; 30:149-153.
26. Coleman DC, Bennet DE, Sullivan DJ, et al. Oral Candida in HIV infection and AIDS: New perspectives/ new approaches. Crit Rev Microbiol 1993; 19: 61-82.
27. McCullough M, Ross B, Reads P. Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus. J Clin Microbiol 1995; 33: 696-700.
28. Wade JC. Epidemiology of Candida Infections. En Bodey GP (Ed) Candidosis: Pathogenesis, diagnosis and treatment. New York, Raven Press, 1993: 85-107
29. Coleman DC, Sullivan DJ, Bennet DE, Moran GP, Barry HJ, Shanley DB. Candidosis: the emergence of a novel species, Candida dubliniensis. AIDS 1997; 11: 557-567
30. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995; 141: 1507-1521.
31. Sullivan D, Haynes K, Bille J, et al. Widespread geographic distribution of oral Candida dubliniensis in human immunodeficiency virus-infected individuals. J Clin Microbiol 1997; 35: 960-964.
32. Moran GP, Sullivan DJ, Henman MC, et al. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother 1997, 41: 617-623.
33. Robinson PG, Challacombe SJ, Sheiham A, Zakrzewska JM. Is erytherrtatous candidiasis associated with advanced HIV disease? Oral Dis 1997; 3 (Suppl 1): S116-S118.